Trial Search Results

Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):

Intervention(s):

  • Procedure: high dose chemo then auto hematopoietic cell transplant

Phase:

N/A

Eligibility


Inclusion Criteria:- relapsed NHL Exclusion Criteria:- liver dysfunction

Ages Eligible for Study

N/A - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Refferals
6507230822